Can an accelerometer enhance the utility of the Timed Up & Go Test when evaluating patients with Parkinson's disease?

Abstract

Accelerometer-derived parameters are sensitive to group differences, indicating that PD patients have poorer mobility during specific aspects of the TUG. In addition to test duration, these measures may serve as complementary and objective bio-markers of PD to augment the evaluation of disease progression and the response to therapeutic interventions.